Literature DB >> 2643423

Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey.

I D Frantz1, E A Dawson, P L Ashman, L C Gatewood, G E Bartsch, K Kuba, E R Brewer.   

Abstract

The Minnesota Coronary Survey was a 4.5-year, open enrollment, single end-time double-blind, randomized clinical trial that was conducted in six Minnesota state mental hospitals and one nursing home. It involved 4393 institutionalized men and 4664 institutionalized women. The trial compared the effects of a 39% fat control diet (18% saturated fat, 5% polyunsaturated fat, 16% monounsaturated fat, 446 mg dietary cholesterol per day) with a 38% fat treatment diet (9% saturated fat, 15% polyunsaturated fat, 14% monounsaturated fat, 166 mg dietary cholesterol per day) on serum cholesterol levels and the incidence of myocardial infarctions, sudden deaths, and all-cause mortality. The mean duration of time on the diets was 384 days, with 1568 subjects consuming the diet for over 2 years. The mean serum cholesterol level in the pre-admission period was 207 mg/dl, falling to 175 mg/dl in the treatment group and 203 mg/dl in the control group. For the entire study population, no differences between the treatment and control groups were observed for cardiovascular events, cardiovascular deaths, or total mortality. A favorable trend for all these end-points occurred in some younger age groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643423     DOI: 10.1161/01.atv.9.1.129

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  71 in total

1.  Hyperlipidemia: Part 1. Evaluation and dietary management.

Authors:  M Tanner; N Link
Journal:  West J Med       Date:  2001-10

Review 2.  The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.

Authors:  Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

Review 3.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

Review 4.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

5.  Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.

Authors:  Patty W Siri-Tarino; Qi Sun; Frank B Hu; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2010-01-13       Impact factor: 7.045

6.  n-6 Fatty acids and risk for CHD: consider all the evidence.

Authors:  William S Harris; Ingeborg A Brouwer; Dariush Mozaffarian
Journal:  Br J Nutr       Date:  2011-06-17       Impact factor: 3.718

7.  Don't disregard the essential distinction between PUFA species.

Authors:  Christopher E Ramsden; Joseph R Hibbeln; Sharon F Majchrzak-Hong; John M Davis
Journal:  Br J Nutr       Date:  2011-06-17       Impact factor: 3.718

8.  Meta-analysis by the Program on the Surgical Control of the Hyperlipidemias (POSCH) investigators.

Authors:  A L Gould; A T Cariski
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

9.  Serum lipids and mood in working men and women in Sweden.

Authors:  G Lindberg; G Larsson; S Setterlind; L Råstam
Journal:  J Epidemiol Community Health       Date:  1994-08       Impact factor: 3.710

Review 10.  Saturated fat, carbohydrate, and cardiovascular disease.

Authors:  Patty W Siri-Tarino; Qi Sun; Frank B Hu; Ronald M Krauss
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.